top of page

Acerca de

hand sanitise.jpg

Impact

Read about the impact of the ACT-Accelerator and access the partnership's reports

gcat-logo-color.png

Tracking progress towards the global targets for access to COVID-19 vaccines, treatments, tests and PPE.

Funding vital research and development of new therapeutics, vaccines, and diagnostics.

Ghana testing.jpeg

Delivering more than 160 million tests to over 180 countries

Scientist Using Microscope

Supporting the market entry of new, affordable rapid tests.

Libya - oxygen cylinders.jpeg

Delivering more than 1.8 billion COVID-19 vaccine doses via the vaccines pillar, COVAX

COVAX pic.jpg

Procuring over US$560 million worth of medical oxygen supplies and repairing 180 PSA plants

Read about the ACT-Accelerator's impact in our quarterly and annual reports:

act-accelerator-strategic-plan cover.png

ACT-Accelerator Transition Report

act-accelerator-strategic-plan cover.png

Q1 Quarterly Update: 1 January – 31 March 2022

act-accelerator-strategic-plan cover.png

Q2 Quarterly Update: 1 April - 30 June 2021

act-accelerator-strategic-plan cover.png

ACT-Accelerator Outcomes Report, 2020-22 (inc Q3 Update)

act-accelerator-strategic-plan cover.png

The ACT-Accelerator: Two years of impact

act-accelerator-strategic-plan cover.png

ACT now, ACT together 2020-2021 Impact Report

act-accelerator-strategic-plan cover.png

Q2 Quarterly Update: 1 April - 30 June 2022

act-accelerator-strategic-plan cover.png

Q4 Quarterly Update: 1 October – 31 December 2021

act-accelerator-strategic-plan cover.png

Investing in the COVID-19 Response through the ACT-Accelerator: Long-Term Benefits

act-accelerator-strategic-plan cover.png

Q3 Quarterly Update: 1 July – 30 September 2021

bottom of page